Potential conflict of interest
TCH has done paid consultancy work for Shionogi and has received lecture fees from Theramex and Shionogi. Rossella E. Nappi has had past financial relationships (lecturer, member of advisory boards and/or consultant) with Boehringer Ingelheim, Ely Lilly, Endoceutics, Gedeon Richter, HRA Pharma, Procter & Gamble Co, TEVA Women's Health Inc and Zambon SpA. At present, she has ongoing relationships with Astellas, Bayer HealthCare AG, Exceltis, Fidia, Merck Sharpe & Dohme, Novo Nordisk, Palatin Technologies, Pfizer Inc, Shionogi Limited and Theramex.
Source of funding
TCH's travel and subsistence to attend the VELA meeting were reimbursed by Fotona.